Previous studies have shown that TGF-β1 contributes to numerous pathophysiological fibrotic courses, whereas TGF-β3 has antifibrotic capabilities particularly in wound healing and in pulmonary and hepatic fibrosis. This evidence concerns the gene TGFB3 and Hepatic fibrosis.